Coronavirus disease (covid-19) vaccine
AssigneeThomas Jefferson University
InventorsMatthias Johannes Schnell, Christoph Wirblich, Drishya Kurup
Life of this patent
Estimating the term…
Abstract
The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof.
Claims30
An isolated nucleic acid encoding a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
A recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof.
A recombinant fusion protein comprising (a) a glycoprotein (G) of a virus or a portion thereof, and (b) a SARS-CoV-2 spike protein (S) or a portion thereof.
A vaccine comprising a recombinant virus comprising a SARS-CoV-2 spike protein (S) or a portion thereof, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.